Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    88,442.73
    +1,147.36 (+1.31%)
     

  • CMC Crypto 200

    1,386.49
    +73.86 (+5.63%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

What's in Store for Alliance Resource (ARLP) in Q2 Earnings?

Zacks Equity Research

Alliance Resource Partners, L.P. ARLP is set to report second-quarter 2019 results on Jul 26, before market open. In the first quarter, the partnership witnessed a positive earnings surprise of 49.28%.

Let’s see how things are shaping up prior to the upcoming results.

Here's What Could Drive Results

In January, Alliance Resource acquired interests in AllDaleMinerals LP and AllDale Minerals II, LP, which provided the partnership access to some of the premier oil and gas production regions in the United States. Alliance Resource gained control of approximately 42,000 net royalty acres in the Anadarko, Permian, Williston and Appalachian basins. We expect the partnership’s second-quarter results to benefit from royalty income generated by these acquired mineral interests.

ADVERTISEMENT

Alliance Resource’s second-quarter earnings are expected to benefit from higher thermal coal export volumes as demand for thermal coal is increasing in Indian Peninsula and other Asian markets.

Q2 Expectations

The Zacks Consensus Estimate for second-quarter 2019 earnings per unit is pegged at 67 cents. The projected figure suggests year-over-year increase of 4.69%. The Zacks Consensus Estimate for second-quarter sales is pegged at $530.02 million, suggesting year-over-year rise of 2.69%.

Earnings Whispers

Our proven model does not show that Alliance Resource is likely to beat earnings this quarter as it does not possess the key components. For a beat, a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.

Alliance Resource Partners, L.P. Price and EPS Surprise

 

Alliance Resource Partners, L.P. Price and EPS Surprise
Alliance Resource Partners, L.P. Price and EPS Surprise

Alliance Resource Partners, L.P. price-eps-surprise | Alliance Resource Partners, L.P. Quote

 

Earnings ESP: The partnership has an Earnings ESP of -19.80%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: Alliance Resource currently carries a Zacks Rank #5 (Strong Sell).

Note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is witnessing negative estimate revisions.

Stocks to Consider

Here are a few companies from the sector that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat in the to-be-reported quarter.

Clearway Energy, Inc CWEN has an Earnings ESP of +15% and sports a Zacks Rank #1. The company is expected to report second-quarter 2019 results on Aug 6.

TOTAL S.A. TOT has an Earnings ESP of +0.38% and a Zacks Rank #3. The company is expected to release second-quarter 2019 results on Jul 25.

Warrior Met Coal Inc HCC has an Earnings ESP of +8.66% and a Zacks Rank #2. The company is expected to report second-quarter 2019 results on Jul 31.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alliance Resource Partners, L.P. (ARLP) : Free Stock Analysis Report
 
Warrior Met Coal Inc. (HCC) : Free Stock Analysis Report
 
TOTAL S.A. (TOT) : Free Stock Analysis Report
 
Clearway Energy, Inc. (CWEN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research